Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 1490010
[patent_doc_number] => 06417002
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-09
[patent_title] => 'Method for maintenance and selection of episomes'
[patent_app_type] => B1
[patent_app_number] => 09/249585
[patent_app_country] => US
[patent_app_date] => 1999-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 9
[patent_no_of_words] => 13411
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/417/06417002.pdf
[firstpage_image] =>[orig_patent_app_number] => 09249585
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/249585 | Method for maintenance and selection of episomes | Feb 10, 1999 | Issued |
Array
(
[id] => 1528741
[patent_doc_number] => 06479654
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF'
[patent_app_type] => B1
[patent_app_number] => 09/244583
[patent_app_country] => US
[patent_app_date] => 1999-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23393
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479654.pdf
[firstpage_image] =>[orig_patent_app_number] => 09244583
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/244583 | Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF | Feb 3, 1999 | Issued |
09/230600 | NOVEL LIPOLYTIC ENZYMES | Jan 26, 1999 | Abandoned |
Array
(
[id] => 1504709
[patent_doc_number] => 06465617
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Identification and characterization of a gene which protects cells from programmed cell death and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/233527
[patent_app_country] => US
[patent_app_date] => 1999-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 23274
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465617.pdf
[firstpage_image] =>[orig_patent_app_number] => 09233527
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/233527 | Identification and characterization of a gene which protects cells from programmed cell death and uses therefor | Jan 19, 1999 | Issued |
09/219698 | TARGETED GENE TRANSFER USING G PROTEIN COUPLED RECEPTORS | Dec 22, 1998 | Abandoned |
Array
(
[id] => 1562348
[patent_doc_number] => 06362326
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-26
[patent_title] => '11 cby genomic sequence'
[patent_app_type] => B1
[patent_app_number] => 09/218467
[patent_app_country] => US
[patent_app_date] => 1998-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 1
[patent_no_of_words] => 12836
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/362/06362326.pdf
[firstpage_image] =>[orig_patent_app_number] => 09218467
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/218467 | 11 cby genomic sequence | Dec 21, 1998 | Issued |
Array
(
[id] => 1546743
[patent_doc_number] => 06444870
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Methods for assessing the role of calcineurin immunosuppression and neurotoxicity'
[patent_app_type] => B1
[patent_app_number] => 09/212868
[patent_app_country] => US
[patent_app_date] => 1998-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31811
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444870.pdf
[firstpage_image] =>[orig_patent_app_number] => 09212868
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/212868 | Methods for assessing the role of calcineurin immunosuppression and neurotoxicity | Dec 15, 1998 | Issued |
09/193834 | METHODS OF CREATING CONSTRUCTS USEFUL FOR INTRODUCING SEQUENCES INTO EMBRYONIC STEM CELLS | Nov 16, 1998 | Abandoned |
09/171802 | GENE EXPRESSION IN MONOCYTES AND MACROPHAGES | Oct 25, 1998 | Abandoned |
Array
(
[id] => 1277166
[patent_doc_number] => 06641526
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Development of normal offspring from oocytes injected with freeze-dried spermatozoa'
[patent_app_type] => B1
[patent_app_number] => 09/177391
[patent_app_country] => US
[patent_app_date] => 1998-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8851
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/641/06641526.pdf
[firstpage_image] =>[orig_patent_app_number] => 09177391
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/177391 | Development of normal offspring from oocytes injected with freeze-dried spermatozoa | Oct 22, 1998 | Issued |
Array
(
[id] => 1338952
[patent_doc_number] => 06593463
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-15
[patent_title] => 'Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems'
[patent_app_type] => B1
[patent_app_number] => 09/175684
[patent_app_country] => US
[patent_app_date] => 1998-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 5140
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/593/06593463.pdf
[firstpage_image] =>[orig_patent_app_number] => 09175684
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/175684 | Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems | Oct 19, 1998 | Issued |
Array
(
[id] => 4343027
[patent_doc_number] => 06284539
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Method for generating dopaminergic cells derived from neural precursors'
[patent_app_type] => 1
[patent_app_number] => 9/169309
[patent_app_country] => US
[patent_app_date] => 1998-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 14611
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284539.pdf
[firstpage_image] =>[orig_patent_app_number] => 169309
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/169309 | Method for generating dopaminergic cells derived from neural precursors | Oct 8, 1998 | Issued |
Array
(
[id] => 1436273
[patent_doc_number] => 06355859
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-12
[patent_title] => 'Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease'
[patent_app_type] => B1
[patent_app_number] => 09/151592
[patent_app_country] => US
[patent_app_date] => 1998-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8287
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/355/06355859.pdf
[firstpage_image] =>[orig_patent_app_number] => 09151592
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/151592 | Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease | Sep 17, 1998 | Issued |
09/148275 | GENE THERAPY FOR TREATMENT OF CANCER | Sep 3, 1998 | Abandoned |
09/135849 | GENE THERAPY FOR REGULATING SMOOTH MUSCLE CELL TONE | Aug 17, 1998 | Abandoned |
Array
(
[id] => 4374537
[patent_doc_number] => 06288301
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Treatment for juvenile diabetes'
[patent_app_type] => 1
[patent_app_number] => 9/127028
[patent_app_country] => US
[patent_app_date] => 1998-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 5783
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/288/06288301.pdf
[firstpage_image] =>[orig_patent_app_number] => 127028
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/127028 | Treatment for juvenile diabetes | Jul 29, 1998 | Issued |
09/034099 | PROTEIN BELONGING TO THE TNF SUPERFAMILY INVOLVED IN SIGNAL TRANSDUCTION, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE THEREOF | Mar 2, 1998 | Abandoned |
Array
(
[id] => 668647
[patent_doc_number] => 07094889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-22
[patent_title] => 'AGE-1 polypeptides and related molecules and methods'
[patent_app_type] => utility
[patent_app_number] => 08/908453
[patent_app_country] => US
[patent_app_date] => 1997-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13585
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/094/07094889.pdf
[firstpage_image] =>[orig_patent_app_number] => 08908453
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/908453 | AGE-1 polypeptides and related molecules and methods | Aug 6, 1997 | Issued |
Array
(
[id] => 1500033
[patent_doc_number] => 06485964
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-26
[patent_title] => 'TRANSGENIC MAMMALS LACKING EXPRESSION OF ERYTHROPOIETIN OR OF ERYTHROPOIETIN RECEPTOR, TRANSGENIC MAMMALS EXPRESSING CHIMERIC ERYTHROPOIETIN RECEPTORS, CONSTRUCTS FOR PRODUCING THE TRANSGENIC MAMMALS AND USES THEREFOR'
[patent_app_type] => B1
[patent_app_number] => 08/839605
[patent_app_country] => US
[patent_app_date] => 1997-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12342
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/485/06485964.pdf
[firstpage_image] =>[orig_patent_app_number] => 08839605
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/839605 | TRANSGENIC MAMMALS LACKING EXPRESSION OF ERYTHROPOIETIN OR OF ERYTHROPOIETIN RECEPTOR, TRANSGENIC MAMMALS EXPRESSING CHIMERIC ERYTHROPOIETIN RECEPTORS, CONSTRUCTS FOR PRODUCING THE TRANSGENIC MAMMALS AND USES THEREFOR | Apr 14, 1997 | Issued |
Array
(
[id] => 515713
[patent_doc_number] => 07192933
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-03-20
[patent_title] => 'Use of a baculovirus to express an exogenous gene in a mammalian cell'
[patent_app_type] => utility
[patent_app_number] => 08/752032
[patent_app_country] => US
[patent_app_date] => 1996-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5252
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/192/07192933.pdf
[firstpage_image] =>[orig_patent_app_number] => 08752032
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/752032 | Use of a baculovirus to express an exogenous gene in a mammalian cell | Nov 18, 1996 | Issued |